SCHEMBL14225431

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL14225418	1.00	APP (0.46)	APPMCHR1CA1CA2CA7
	SCHEMBL19521918	1.00	APP (0.46)	APPMCHR1CA1CA2CA7
	SCHEMBL14225415	0.98	APP (0.47)	APPMCHR1CA1CA2CA7
	SCHEMBL14225439	0.91	APP (0.43)	APPMCHR1CA1CA2CA7
	SCHEMBL17431884	0.90	APP (0.38)	APPMCHR1CA1CA2CA7
	SCHEMBL17431908	0.87	APP (0.57)	APPMCHR1CA1CA2CA7
	SCHEMBL17431906	0.85	APP (0.37)	APPMCHR1CA1CA2CA7
	SCHEMBL17790458	0.85	APP (0.59)	APPMCHR1CA1CA2CA7
	SCHEMBL14225424	0.83	EGFR (0.40)	APPMCHR1CA1CA2CA7
	SCHEMBL14225436	0.82	CTSA (0.39)	APPMCHR1CTSAEGFRAURKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.